Results 31 to 40 of about 40,449 (228)

The study of consistent properties of the vasopressin nasal dosage form

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2016
Evaluation of consistent properties is an important and integral part of investigations on the creation of semisolid nasal pharmacotherapeutic agents. The aim of this work is the study of consistent properties of developed nasal semisolid dosage form ...
Al Nukarii Abdulkarim   +2 more
doaj   +1 more source

Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients [PDF]

open access: yes, 1993
Glucocorticoid hormones suppress the secretion of ACTH evoked by secretagogues such as CRF and arginine vasopressin. In this study, we investigated the effects of glucocorticoids on ACTH release induced by oxytocin (OT) and on intracellular free calcium ...
Dayanithi, G., Gratzl, Manfred, Link, H.
core   +1 more source

Anesthetic experience of frontotemporal dementia patient with severe autonomic dysfunction: a case report [PDF]

open access: yesKorean Journal of Anesthesiology, 2017
Anesthetic experience in frontotemporal dementia (FTD) with severe hypotension associated autonomic dysfunction has not yet been reported. Here in case, we report on the case of treatment with vasopressin to refractory hypotension in FTD patient.
Hyae-Jin Kim   +7 more
doaj   +1 more source

UNDULY ENHANCED RESPONSE TO TOLVAPTAN IN A WOMAN SHOWING SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION: AN INVESTIGATION OF POSSIBLE CAUSES [PDF]

open access: yes, 2017
Objective: To investigate possible causes of an excessive response to tolvaptan in a woman with syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Lanzellotti, Davide   +4 more
core   +1 more source

Vasopressin and its analogues in shock states: a review

open access: yesAnnals of Intensive Care, 2020
Activation of arginine–vasopressin is one of the hormonal responses to face vasodilation-related hypotension. Released from the post-pituitary gland, vasopressin induces vasoconstriction through the activation of V1a receptors located on vascular smooth ...
Julien Demiselle   +3 more
doaj   +1 more source

Drugs for the treatment of central diabetes insipidus: historical background and modern opportunities

open access: yesОжирение и метаболизм, 2017
Central diabetes insipidus is a severe disease with disturbance of arginine vasopressin secretion, which leads to excretion of large amounts of hypotonic urine.
Dar'ya S. Mikhaylova   +2 more
doaj   +1 more source

Effect of vasopressin 1b receptor blockade on the hypothalamic-pituitary-adrenal response of chronically stressed rats to a heterotypic stressor [PDF]

open access: yes, 2009
Exposure to chronic restraint (CR) modifies the hypothalamic–pituitary–adrenal (HPA) axis response to subsequent acute stressors with adaptation of the response to a homotypic and sensitization of the response to a heterotypic stressor. Since vasopressin
Craighead, Mark   +5 more
core   +1 more source

The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department

open access: yesBMC Medicine, 2012
The hypothalamic-pituitary-adrenal axis is activated in response to stress. One of the activated hypothalamic hormones is arginine vasopressin, a hormone involved in hemodynamics and osmoregulation.
Nickel Christian H   +2 more
doaj   +1 more source

Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus

open access: yesArchives of Endocrinology and Metabolism, 2022
“What's in a name? That which we call a rose / By any other name would smell as sweet” (Juliet, from Romeo and Juliet by William Shakespeare). Shakespeare's implication is that a name is nothing but a word and it therefore represents a convention with no
Hiroshi Arima   +10 more
doaj   +1 more source

Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration [PDF]

open access: yes, 2014
Cisplatin is a highly emetogenic cancer chemotherapy agent, which is often used to induce nausea and emesis in animal models. The cytotoxic properties of cisplatin also cause adverse events that negatively impact on animal welfare preventing repeated ...
A Tidholm   +46 more
core   +3 more sources

Home - About - Disclaimer - Privacy